SCHEMBL7945422

SCHEMBL7945422

O=C(O)c1c(-c2cnc3[nH]ccc3c2)csc1NC(=O)C1Cc2ccccc2O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ GLS O94925 2/20 0.39
▸ CDK8 P49336 4/20 0.38
▸ AXL P30530 2/20 0.38
▸ ABL1 P00519 2/20 0.37
▸ ALOX5AP P20292 1/20 0.37
▸ FEN1 P39748 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ PIK3C3 Q8NEB9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12831059 0.85 NFKB1 (0.39) NFKB1NFKB2RELAGLSCDK8
SCHEMBL1950495 0.79 MEN1 (0.49) NFKB1NFKB2RELAGLSMEN1
SCHEMBL7955760 0.78 KMT2A (0.43) NFKB1NFKB2RELAGLSMEN1
SCHEMBL7950069 0.78 NFKB1 (0.42) NFKB1NFKB2RELAGLSMEN1
SCHEMBL2180368 0.74 MEN1 (0.47) NFKB1NFKB2RELACDK8AXL
SCHEMBL7951000 0.73 NFKB1 (0.42) NFKB1NFKB2RELAGLSMEN1
SCHEMBL1950210 0.71 ANO1 (0.55) GLSANO1
SCHEMBL27260532 0.70 HDAC6 (0.54) NFKB1NFKB2RELAGLSABL1
SCHEMBL1954085 0.69 ANO1 (0.53) GLSMEN1KMT2AANO1
SCHEMBL12271221 0.69 MEN1 (0.56) GLSMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010025295-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2010-03-04 — — WO disclosed
Send feedback